5E Advanced Materials (FEAM) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
22 Jan, 2026Executive summary
Fiscal 2024 saw significant progress: EPA approval, small scale facility startup, first production, and initial customer sample shipments in June.
Goals for fiscal 2025 include completing phase one engineering for a 90,000-ton boric acid facility, securing offtake agreements, and advancing project finance diligence.
Recent $10 million capital raise provides runway to complete first phase of commercial engineering and supports ongoing operations and customer qualification.
Financial highlights
$10 million capital raise: $4 million from new equity and $6 million in convertible notes.
Current production rate at small scale facility is one short ton per day, balancing liquidity and operational needs.
Cost optimization efforts underway, including process improvements and mine plan adjustments to reduce OpEx and CapEx.
Outlook and guidance
First phase of commercial plant engineering targeted for completion by December 2024 or January 2025.
Ongoing pursuit of offtake agreements and commercial partnerships for byproducts.
Anticipates production-based revenues in fiscal 2025 as customer qualification progresses and excess inventory is sold.
Latest events from 5E Advanced Materials
- Net loss improved and key milestones achieved, but ongoing operations require new funding.FEAM
Q2 202617 Feb 2026 - Advancing U.S. boron project targets supply gaps and critical mineral status amid rising demand.FEAM
LD Micro Main Event XIX Investor Conference3 Feb 2026 - Leadership changes and operational progress drive growth and commercial execution.FEAM
Status Update1 Feb 2026 - Raising up to $30M for boron/lithium project, but faces high risk and needs more capital.FEAM
Registration Filing27 Jan 2026 - First boric acid sales, cost savings, and liquidity challenges amid new financing.FEAM
Q1 202513 Jan 2026 - Major noteholders may sell up to 41.9M shares after note conversion; company receives no proceeds.FEAM
Registration Filing16 Dec 2025 - Up to 10.7M shares registered for resale via warrants; proceeds support general operations.FEAM
Registration Filing16 Dec 2025 - Registration enables resale of convertible note shares; no proceeds to company; high risk profile.FEAM
Registration Filing16 Dec 2025 - Up to 20.6M shares registered for resale post-restructuring; no proceeds to the company.FEAM
Registration Filing16 Dec 2025